INDP (Indaptus Therapeutics Inc) Sof foyda

INDP (Indaptus Therapeutics, Inc.) - kompaniyaning tovar belgisi

Saraton va infeksiyalarni davolash uchun xavfsiz usullar qanday yaratilishi mumkin? GURU.Markets platformasidagi Indaptus Therapeutics (INDP) kompaniyasining joriy foydasi bo'yicha ushbu grafik -0.02 ko'rsatkichning joriy holatini tavsiflovchi tendentsiyani aks ettiradi. Yechim sifatida tadqiqot markazlari va hamkor ishlab chiqarish korxonalarining uzluksiz faoliyati ko'magida immunofarmatsevtika bozorini egallash uchun Decoy onkologiya platformasini kengaytirish ko'zda tutilgan.

INDP (Indaptus Therapeutics) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

Indaptus Therapeutics, Inc. (INDP) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Indaptus Corp|INDP - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Indaptus Corp|INDP - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Indaptus Therapeutics|INDP - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi indaptusrx.com|INDP - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Indaptus Therapeutics|INDP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Indaptus Therapeutics Inc|INDP - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Indaptus Corp|INDP - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Indaptus Therapeutics|Shoshilinch likvidlik indaptusrx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
INDP - Sof foyda
Kompaniyaning jamlanma tahlili:Indaptus Therapeutics
Indaptus asosiy tovari

Indaptus Therapeutics (INDP) kompaniyasining sof operatsion foyda dinamikasi pul oqimlarining kumulyativ effektini aks ettiradi, bu esa investorlarga fundamental biznes muvaffaqiyatlarining real vaqt rejimida qanchalik tezlik bilan kapitalizatsiya qilinishini baholash imkonini beradi. Indaptus Therapeutics (INDP) uchun ushbu ko'rsatkich universal immunoterapiya rivojlanishiga bo'lgan bozor ishonchining o'lchovi bo'lib xizmat qiladi, bunda grafikdagi har qanday keskin ko'tarilish onkologiya va gepatitga qarshi kurashda bakterial dori vositalarining salohiyatiga ijobiy baho berilganligini anglatadi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniya foydasi UPB|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniya foydasi IMNM (Immunome Inc)|Sof foyda GOSS|Sof foyda KalVista Corp (KALV)|Kompaniyaning sof foydasi Septerna Inc SEPN|PVLA (pieris.com) - Soliqdan keyingi foyda|SVRA: Sof daromad|Rigel Pharma - Soliqlar to‘langandan keyingi foyda|ANAB (AnaptysBio Corp) - Sof daromad|Astria Corp (ATXS) - Sof foyda|Kompaniyaning sof foydasi enGene Holdings Inc.|rapt.com (RAPT) - Sof moliyaviy natija|Sof daromad JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics Inc.) - Yakuniy foyda|Kyverna - Sof daromad|Soliqlar to‘langandan keyingi foyda TLSA (Tiziana Life Sciences, Ltd.)|Cabaletta Bio, Inc. - Sof foyda|Yakuniy foyda VTYX (ventyxbio.com)|THTX: Sof foyda|Kompaniyaning sof daromadi Avalo Therapeutics, Inc. (AVTX)|Kompaniyaning sof foydasi Eledon|AGEN: Yakuniy foyda|Sof foyda CLYM|Sof foyda zurabio.com (ZURA)|Kompaniyaning sof foydasi aTyr Pharma ATYR|ADAG (Adagene Inc) - Soliqdan keyingi foyda|Ikena Oncology, Inc. - Sof foyda|Kompaniyaning sof daromadi Shattuck Labs, Inc.|EQ (equilliumbio.com) - Sof daromad|Connect Biopharma Holdings Limited (CNTB) - Sof foyda|Sof daromad IMUX|ATRA (Atara Biotherapeutics Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda IFRX|Sof moliyaviy natija X4 Pharmaceuticals, Inc|Sof foyda ACET (Adicet Bio, Inc.)|CELU - Sof daromad|INMB - Kompaniyaning sof foydasi|Sof moliyaviy natija Barinthus Biotherapeutics PLC BRNS|KZR: Sof foyda|SABS - Sof moliyaviy natija|Kompaniyaning sof foydasi Akari Therapeutics|Kompaniya foydasi ENLV (Enlivex Therapeutics, Ltd.)|Sof foyda QTTB|GeoVax Labs - Kompaniya foydasi|Kompaniyaning sof foydasi Edesa EDSA|IBIO (iBio Corporation) - Soliqdan keyingi foyda|CARM - Kompaniyaning sof foydasi|Soliqdan keyingi foyda XTLB|BOLT: Sof foyda|HCW Biologics - Yakuniy foyda|APVO (Aptevo Therapeutics, Inc.) - Sof foyda|Sof foyda aimimmuno.com|Kompaniyaning sof foydasi Aditxt (ADTX)|GRI (gribio.com) - Yakuniy foyda|Kompaniyaning sof foydasi XORTX Therapeutics XRTX|HIND - Sof daromad|Revelation Bio - Sof foyda|SCNI - Sof foyda|CALI (calcimedica.com) - Sof daromad|Affimed N.V. - Yakuniy foyda|ALLK (Allakos Inc) - Sof foyda|HOOKIPA (HOOK) - Sof moliyaviy natija|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD: Sof daromad